PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.36%
Revenue growth above 1.5x NXPI's 3.21%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
15.92%
Gross profit growth above 1.5x NXPI's 0.13%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
75.90%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
75.90%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
14.77%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
-15.38%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-16.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
50.74%
Slight or no buybacks while NXPI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
51.98%
Slight or no buyback while NXPI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-35.45%
Dividend reduction while NXPI stands at 0.12%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
109.22%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
186.64%
FCF growth above 1.5x NXPI's 94.26%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-48.19%
Negative 10Y revenue/share CAGR while NXPI stands at 79.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
21.71%
5Y revenue/share CAGR under 50% of NXPI's 77.31%. Michael Burry would suspect a significant competitive gap or product weakness.
-38.73%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
36.94%
10Y OCF/share CAGR under 50% of NXPI's 104.58%. Michael Burry would worry about a persistent underperformance in cash creation.
120.38%
5Y OCF/share CAGR 1.25-1.5x NXPI's 107.18%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
8.97%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
71.28%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
137.70%
Below 50% of NXPI's 328.95%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-45.79%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
127.57%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
59.18%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
-36.96%
Negative 3Y equity/share growth while NXPI is at 42.98%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-5.96%
Cut dividends over 10 years while NXPI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-4.47%
Negative 5Y dividend/share CAGR while NXPI stands at 169.49%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-34.92%
Negative near-term dividend growth while NXPI invests at 20.43%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-4.66%
Firm’s AR is declining while NXPI shows 1.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.11%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.81%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-31.13%
We have a declining book value while NXPI shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.48%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-4.27%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.60%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.